IL17A and psoriasis: This hormone further regulates immune cells and cutaneous cells, promoting the release of core pro-inflammatory cytokines such as IL-6, IL-17, and TNF-α, ultimately exacerbating the severity of psoriatic lesions and prolonging the chronicity of psoriasis.